09 Sep 2016
LIBERUM: Genus – Further upside rests on gene editing
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
LIBERUM: Genus – Further upside rests on gene editing
Genus plc (GNS:LON) | 1,791 35.8 0.1% | Mkt Cap: 1,183m
- Published:
09 Sep 2016 -
Author:
Sophie Jourdier | Lisa De Neve -
Pages:
16